User Was Automatically Signed Out Due To Idling For 30 Minutes

عربي

Login

Government Agency
Email
User Name

Password

Forgot your password?
Don't have an account? Create an account now

Register by

Create an account


Have Account Sign In Now

Consultations

advanced search

Consultation Count: 197

Sort By

Agency Name: Alimony Fund-public Administration

Consultation on the Core Ex Ante Legislative Impact Assessment Study

The preparation of this study falls within the framework of applying the principles of good regulation and legislative impact assessment to regulatory interventions. It aims to analyze the regulatory and financial challenges associated with the framework governing the Alimony Loan Fund, and to demonstrate the need to amend the existing framework in a manner that aligns with the Fund’s legal status as a financially and administratively independent legal entity. The study reviews the challenges related to the Fund’s financial sustainability in light of the growing volume of loan disbursements compared to limited recovery rates. It also examines possible regulatory alternatives and their anticipated impacts, with a view to identifying the most appropriate regulatory option. This consultation aims to provide stakeholders and interested parties with the opportunity to review the study’s findings and submit their observations prior to the completion of the formal legislative procedures.

Consultation Period

13/04/2026 - 13/05/2026

Consultation Status

Opened

30 Day : 6 Hour : 29 Minute

7
0
More Details

Agency Name: Jordan Food and Drug Administration

JFDA Guideline for Registration of Biosimilars 2026

The Jordan Food and Drug Administration (JFDA) has updated its biosimilars guideline to align with the latest global advancements and regulatory expectations, particularly those established by the European Medicines Agency (EMA) and its updated biosimilars guidelines, in addition to other reference health authorities such as US FDA and the WHO Biosimilars related guidelines. This revision reflects the evolving scientific understanding and regulatory landscape surrounding biosimilar development, emphasizing the importance of a tailored clinical development approach that is both scientifically justified and resource-efficient. Recent international experiences and scientific progress have demonstrated that comprehensive analytical characterization and comparative pharmacokinetic data can, under specific conditions, sufficiently establish bio-similarity without necessitating extensive clinical efficacy trials for every biosimilar candidate. The updated guideline incorporates these insights to streamline biosimilar development while maintaining rigorous standards for demonstrating similarity in quality, safety, and efficacy.

Consultation Period

13/04/2026 - 13/05/2026

Consultation Status

Opened

30 Day : 6 Hour : 29 Minute

9
0
More Details

Agency Name: Legislation and Opinion Bureau

Reward and Savings Fund System for Employees of the University of Jordan

To ensure that the reward system and savings fund for employees of the University of Jordan comply with the Jordanian Universities Law, keep pace with current developments in university-related legislation, and guarantee its consistency with the Social Security Law, this draft system has been prepared.

Consultation Period

07/04/2026 - 17/04/2026

Consultation Status

Opened

4 Day : 6 Hour : 29 Minute

37
0
More Details

Agency Name: Legislation and Opinion Bureau

System for using electronic means and modern technologies, subscription data, and documents related to the Sharia court

To establish a binding and sustainable regulatory framework for the use of electronic means and cutting-edge technologies in judicial and administrative procedures within Sharia courts and their affiliated departments. To ensure the standardization of procedures, enhance their reliability, improve the quality of services, and reduce their time and cost. To strengthen governance and institutional agility, thereby raising the level of service recipients. Therefore, this draft system has been developed.

Consultation Period

02/04/2026 - 11/04/2026

Consultation Status

Closed

Closed

17
0
More Details

Agency Name: Jordan Securities Commission

ESG Code

The Jordan Securities Commission (JSC) announces the publication of the Environmental, Social, and Governance (ESG) Code for public consultation with companies listed on the Amman Stock Exchange ASE20 Index, alongside key stakeholders and market participants. This Code represents a strategic milestone in advancing Jordan’s capital market, reinforcing JSC’s commitment to building a transparent, resilient, and future-ready investment environment aligned with global sustainability expectations. Developed in response to accelerating global shifts in sustainable finance, the ESG Code establishes a robust framework for governance, risk management, and disclosure of sustainability-related risks and opportunities, enabling companies to better position themselves for long-term value creation and competitiveness. The Code is fully aligned with the global baseline set by the International Sustainability Standards Board (ISSB), including IFRS S1 and IFRS S2, positioning Jordan among markets proactively adopting internationally recognized sustainability disclosure standards. Implementation will follow a phased approach, with ASE20 listed companies forming the first group required to apply the Code starting from the 2027 financial year under an “apply and explain” principle. This approach ensures both accountability and flexibility, while driving meaningful integration of ESG practices into corporate strategy and reporting. Through this initiative, the JSC aims to enhance investor confidence, improve the quality and comparability of disclosures, and strengthen Jordan’s positioning as an attractive destination for sustainable investment. The JSC invites all relevant stakeholders to provide their feedback and insights on the Code, as part of a collaborative process to ensure its effective implementation and alignment with both market realities and international best practices.

Consultation Period

30/03/2026 - 12/04/2026

Consultation Status

Closed

Closed

117
8
More Details

Agency Name: Jordan Securities Commission

ESG Code

Abstract: The Jordan Securities Commission (JSC) announces the publication of the Environmental, Social, and Governance (ESG) Code for public consultation with companies listed on the Amman Stock Exchange ASE20 Index, alongside key stakeholders and market participants. This Code represents a strategic milestone in advancing Jordan’s capital market, reinforcing JSC’s commitment to building a transparent, resilient, and future-ready investment environment aligned with global sustainability expectations. Developed in response to accelerating global shifts in sustainable finance, the ESG Code establishes a robust framework for governance, risk management, and disclosure of sustainability-related risks and opportunities, enabling companies to better position themselves for long-term value creation and competitiveness. The Code is fully aligned with the global baseline set by the International Sustainability Standards Board (ISSB), including IFRS S1 and IFRS S2, positioning Jordan among markets proactively adopting internationally recognized sustainability disclosure standards. Implementation will follow a phased approach, with ASE20 listed companies forming the first group required to apply the Code starting from the 2027 financial year under an “apply and explain” principle. This approach ensures both accountability and flexibility, while driving meaningful integration of ESG practices into corporate strategy and reporting. Through this initiative, the JSC aims to enhance investor confidence, improve the quality and comparability of disclosures, and strengthen Jordan’s positioning as an attractive destination for sustainable investment. The JSC invites all relevant stakeholders to provide their feedback and insights on the Code, as part of a collaborative process to ensure its effective implementation and alignment with both market realities and international best practices.

Consultation Period

30/03/2026 - 12/04/2026

Consultation Status

Closed

Closed

82
3
More Details

Agency Name: Jordan Food and Drug Administration

Guideline for the Import of Registered Infant Formulas, Special Formulas, and Their Complementary Foods

This guideline provides a regulatory framework for the import of registered infant formulas, special formulas, and their complementary foods. It ensures that all imported products comply with quality, safety, and nutritional standards, adhere to national health and regulatory requirements, protect infant health, support proper nutrition, and specifies the import requirements for these products.

Consultation Period

26/03/2026 - 26/04/2026

Consultation Status

Opened

13 Day : 6 Hour : 29 Minute

10
2
More Details

Agency Name: Jordan Food and Drug Administration

Guideline for the Import of Radioactive Materials and Pharmaceutical products Used in Nuclear Medicine

This guideline provides a regulatory framework for the import of radioactive materials and pharmaceutical products used in nuclear medicine. It ensures that all imported products comply with quality, safety, and efficacy standards, are handled, transported, and used in accordance with national health and regulatory requirements, protecting public health and safety, and specifies the import requirements for these products.

Consultation Period

26/03/2026 - 26/04/2026

Consultation Status

Opened

13 Day : 6 Hour : 29 Minute

13
2
More Details

Agency Name: Jordan Food and Drug Administration

Guideline for the Import of Narcotic Substances, Psychotropic Agents, and Narcotic Preparations Listed in the Schedules of Narcotic Substances, Psychotropic Agents, and Chemical Precursors Supplementing the Narcotic and Psychotropic Substances Law No. 23 of 2026

This guideline provides a regulatory framework for the import of narcotic substances, psychotropic agents, and narcotic preparations listed in the schedules of narcotic substances, psychotropic agents, and chemical precursors under Law No. 23 of 2026. It ensures that all imported substances are used safely and legally, in compliance with national and international regulations, protecting public health and preventing misuse, and specifies the import requirements for these substances.

Consultation Period

26/03/2026 - 26/04/2026

Consultation Status

Opened

13 Day : 6 Hour : 29 Minute

42
5
More Details

Agency Name: Jordan Food and Drug Administration

Guideline for the Import of Personal Parcels

This guideline provides a regulatory framework for the import of personal parcels, ensuring that all items entering the country comply with national health, safety, and regulatory standards. It provides a framework to monitor and control their contents, facilitates lawful and safe importation, and specifies the import requirements for these parcels.

Consultation Period

26/03/2026 - 26/04/2026

Consultation Status

Opened

13 Day : 6 Hour : 29 Minute

5
0
More Details

Need a little help?

To adjust this website for your accessibility needs, select one or more options below.

Reset All